MDNA   $0.157  -13.16% Market Closed

Medicenna Therapeutics Corp
Total Cash 29.61M
totalCashPerShare 0.425
EBITDA -16.44M
Total Debt 0.00
quickRatio 6.554
currentRatio 6.777
Total Revenue
debtToEquity
Revenue/Share
ROA -0.39740002
ROE -0.39004
grossProfits
freeCashflow -7.61M
operatingCashflow -13.82M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -17.29M
forwardPE -0.7476191
floatShares 48.76M
sharesOutstanding 69.64M
sharesShort 109.39K
sharesShortPriorMonth 278.17K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.24%
heldPercentInstitutions 0.14%
Short Ratio help_outline 0.77%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 0.386
Price To Book help_outline 0.41
earningsQuarterlyGrowth
netIncomeToCommon -8.76M
trailingEps -0.09%
forwardEps -0.21%
enterpriseToEbitda 1.05
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.05 3Q 2023
institutionsCount 31
lastUpdated Dec. 31, 2023, 8:59 p.m.